ChinaBio Today -- ReSearch Pharmaceutical Services (RPS), a US-headquartered international CRO, will acquire Paramax International for $1 million and 530,973 shares of RPS common stock. Paramax is a CRO that is based in Beijing with offices in other China cities. RPS positioned the acquisition as an expansion of its global CRO business. The company bought three European CROs in late 2008, and it has operations in Central and South America as well. Paramax is the company’s first foray into Asia. More details..
